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INTRODUCTION 
Neonatal cholestasis is one of the commonest liver problem in 
neonates and infants. Various diseases of different etiology result in 
neonatal cholestasis. The etiology may be infectious, endocrine, genetic, 
metabolic, congenital, toxic or inflammatory. 
The two major causes of neonatal cholestasis are biliary atresia and 
idiopathic neonatal hepatitis. Many cases previously described as 
idiopathic neonatal hepatitis have been found to have genetic basis and 
now they have been reclassified as metabolic diseases. Almost all these 
diseases manifest with jaundice, elevated liver enzymes, cholestasis and 
nutritional deficiency. While some diseases improve with supportive 
treatments, others progress to chronic liver disease and cirrhosis. 
CAUSES  
The major causes of neonatal cholestasis may be classified as 
follows; 
1. Infection 
Toxoplasmosis 
Rubella 
Cytomegalovirus 
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Herpes simplex virus 
Varicella-Zoster virus 
HBV 
Syphilis  
HCV 
Human immunodeficiency virus 
Parvo virus B19 
Syncitial giant cell virus 
Listeria 
Tuberculosis 
Sepsis 
UTI 
2. Genetic 
Trisomy 21 
Trisomy 18 
Cat-eye syndrome 
3. Endocrine 
Hypopituitrism 
Hypothyroidism 
4. Structural 
Extra Hepatic Biliary Atresia (EHBA) 
Choledochal cyst 
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Neonatal Sclerosing Cholangitis 
Inspissated Bile 
 Spontaneous perforation of common bile duct  
5. Duct paucity syndrome 
Alagille syndrome 
Non syndromic bile ductular hypoplasia 
6. Metabolic 
Alpha-1-Antitrypsin deficiency 
Cystic fibrosis 
Galactosemia 
Tyrosinemia 
Hereditary Fructosemia 
GSD Type 4 
Niemann - Pick type A & C 
Primary disorders of bile acid synthesis 
Byler disease 
Wolman disease 
Zellweger syndrome 
7. Immune 
Neonatal lupus erythematosus 
Neonatal hepatitis with autoimmune hemolytic anemia 
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CLINICAL FEATURES 
The symptoms and signs commonly seen in all these disorders 
-Jaundice 
-Pale stools and dark urine 
-Hepatomegaly 
-Splenomegaly 
-Ascites in some cases 
-Deficiency of fat soluble vitamins 
-Failure to thrive 
The following symptoms and signs are peculiar to certain diseases 
and they aid in their diagnosis 
1. Small for gestation: Alagille syndrome 
 Metabolic liver disease 
 Intrauterine infection 
2. Dysmorphic facies: Trisomy 18 & Trisomy 21 
 Zellweger syndrome  
 Alagille syndrome 
3. Hypoglycemia:      Hypopituitarism 
Metabolic liver disease 
Severe liver disease 
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4. Associated other system anomalies: 
Polysplenia/Asplenia - EHBA 
Neurodegeneration   - Niemann-Pick disease 
PDA, PS, Vertebral anomaly-Alagille syndrome 
Snuffles, osteitits –Congenital Syphilis 
INVESTIGATIONS 
1. Serum bilirubin – elevated in all cases of neonatal cholestasis. 
When the direct fraction is more than 20% of total bilirubin, it 
indicates cholestasis. 
2. Liver enzymes (AST, ALT) – elevated in almost all cases of 
neonatal cholestasis. Not particularly useful in the differential 
diagnosis of neonatal cholestasis. Markedly elevated levels (>800 
u/l) indicate hepatocellular damage as the cause of cholestasis. 
However in some cases of acute biliary obstruction, 
aminotransferase are elevated similarly because of secondary 
hepatocellular damage. 
3. GGT – elevated in most cases. But will be normal or low in cases 
of Byler’s disease, and primary bile acid synthesis defect. GGT is 
more specific than alkaline phosphatase as a indicator of damage to 
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biliary radicals, as alkaline phosphatase is also secreted by bones in 
growing children. 
4. Serum albumin – Usually normal, unless there is severe liver 
disease. 
5. PT & PTT – prolonged in severe liver disease / vitamin K 
efficiency. 
6. Abdominal ultrasound – non visualization of gallbladder and 
positive ‘TRIANGULAR CORD’ sign are features of EHBA. 
Recent studies have suggested the use of gallbladder ghost triad 
and hepatic arterial diameter in predicting biliary atresia. 
Choledochal cyst, inspissated bile, coexistent congenital 
malformation like polysplenia, asplenia, situs anomalies can be 
made out with ultrasound. 
7. Radioisotope scan: Used to demonstrate hepatic uptake and biliary 
excretion into the gut. Useful to rule out EHBA 
8. Liver Biopsy- The most informative of all investigations. It helps 
in assessing the severity of hepatocellular involvement and extent 
of fibrosis, identifying features of EHBA and differentiating it 
from hypoplasia of bile duct, identifying infiltrative / storage / 
infectious diseases. 
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Hepatocellular damage with formation of multinucleated giant cells 
is a non-specific finding. Bile duct proliferation is said to be prominent in 
bile duct obstruction, but it also occurs in children with neonatal hepatitis 
syndrome, particularly those with Alpha-1-Antitrypsin deficiency, Cystic 
fibrosis, and endocrine deficiency. 
SPECIFIC INVESTIGATIONS 
1. Antibody assay- Infections like TORCH, Parvovirus B19, HIV, 
HBV and HCV 
2. Urine culture – CMV, UTI 
3. Blood culture – Sepsis 
4. TSH, T3, T4, cortisol - Hypopituitarism, Hypothyroidism 
5. Karyotyping – Trisomy 18, 21 
6. Serum A1AT, PI Phenotype – Alpha-1-Antitrypsin deficiency 
7. Sweat chloride – Cystic fibrosis 
8. RBC Gal-1-phosphate uridyl transferase – Galactosemia 
9. Serum tyrosine, AFP, urine succinylacetone - Tyrosinemia 
10. BM aspirate, Liver, Rectal biopsy – Niemann-Pick disease 
11. Urine bile acid study by FAB-MS–primary bile acid synthesis 
defect.  
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MANAGEMENT 
1. Supportive treatment 
Nutritional support 
Fat soluble vitamins  
Management of cholestasis and pruritus 
2. Specific treatment 
Nutritional support 
Infants with neonatal cholestasis have increased resting energy 
expenditure-about 30% higher than in normal infants of the same sex and 
age1. Thus the calorie intake should be 120-150% of estimated average 
requirement. Infants taking breast feeds adequately should have 
supplementation with easily digestible high calorie density formula. 
Growth monitoring should be done in  all children and appropriate 
measures to correct nutritional deficit should be undertaken.  
Fat soluble vitamin supplementation 
Vitamin A               - 5000-25000 units/day 
Vitamin D               - 800-5000 units/day 
Vitamin E                - 15-25 IU/Kg/day 
Vitamin k                - 2.5 mg twice/week 
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Management of cholestasis and Pruritus 
1. Cholestyramine- 1-4 g daily 
2. UDCA – 15-30 mg/kg/day 
3. Phenobarbitone – 5-10 mg/kg/day 
4. Rifampicin – 5-10 mg/kg/day 
SPECIFIC TREATMENT 
1. Toxoplasmosis                                    - Spiramycin 
2. CMV hepatitis                     - Gancyclovir 
3. HSV                                                     - Acyclovir 
4. Syphilis                                                 - Penicillin 
5. Sepsis / UTI                                          - Appropriate antibiotics 
6. Tuberculosis                                          - ATT 
7. Syncitial giant cell hepatitis                  - Ribavirin 
8. Panhypopituiarism                                - Corticosterone, thyroxine 
9. EHBA                                                   - Kasai’s portoenterostomy 
10. Choledochal cyst                                  - Surgical resection 
11. Spontaneous perforation of CBD         - Surgical repair 
12. Primary bile acid synthesis defect        - Bile acid supplementation 
13. Drug induced                                         - Stop causative drug   
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EXTRAHEPATIC BILIARY ATRESIA 
HISTORY OF BILIARY ATRESIA 
 1891: Thompson from Edinburgh reported a series of infants dying 
of liver failure secondary to congenital biliary atresia.2  
1935: Ladd from Boston, USA, first described successful operation 
for ‘correctable’ types of biliary atresia; wherein atretic segments was 
limited to the common bile duct and hepatic ducts with patency of 
proximal biliary tree. 
1959: Morio Kasai, a Japanese surgeon, first described 
Portoenterostomy- with increasing number of children having their 
jaundice cleared and surviving for longer periods.3,4 
INCIDENCE OF BILIARY ATRESIA 
It is a rare disease with incidence of 1:10,000 live births. Slight 
female  preponderance has been described.5 
DEFINITION 
Biliary atresia is an idiopathic, localized complete obliteration or 
discontinuity of hepatic or common bile duct - at any point from the porta 
hepatic to the duodenum.6,7 
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PATHOGENESIS 
Biliary atresia is a cholangiopathic panductular disease. The 
histologicalappearances in biliary atresia8 are characterized by  
                          -bile duct plugging. 
                          -bile ductular proliferation. 
                          -portal edema. 
                          -variable giant cell formation. 
The intrahepatic ducts are also affected in all cases of biliary 
atresia. Three types of biliary atresia are classified on the basis of the 
level of atresia of hepatic tree. 
Type 1- Atretic common bile duct. 
Type 2- Atretic common hepatic duct. 
Type 3- Atresia of all hepatic ducts 
Type 3 is most common accounting for 85% of all cases. Types 1 and 2 
are less common and they carry a better prognosis. 
Two types of biliary atresia have been described.9  
- Embryonic form: With associated anomalies, thought to be due to 
intrauterine insults / infections. 
 12
- Perinatal form: Thought be due to viral infection-probably reo or 
rota virus.                     
ETIOLOGY 
Congenital hepatic embryopathy :  Bile duct, spleen, portal vein, 
inferior vena cava –all structures develop by 25-40 days of gestation. In 
about 10% of cases of biliary atresia, the cholangiopathy is accompanied 
by malformation of spleen (polysplenia/asplenia) known as biliary atresia 
spleen malformation (BASM) 10.  
 Thus an ‘insult ’occurring in early phase of development may be a 
cause of these anomalies. One study showed an association between 
gestational diabetes mellitus and BASM.10 
There is histological and immunohistochemical similarity between 
hepaobiliary system developing at 11-13 weeks of gestation and a well 
established case of biliary atresia. Thus it has been suggested that biliary 
atresia without syndromic features may represent an arrested 
development of biliary radicals. 
A small number of biliary atresia cases had gestational ultrasound 
anomalies from 17 weeks. GGT is an enzyme of fetal liver origin found 
in amniotic fluid from second trimester onwards and it relates to in-utero 
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bile production and defecation. A large study of amniotic fluid sampling 
showed that children born with biliary atresia had minimal levels of 
amniotic fluid GGT at 18 weeks gestation11. 
Viral studies : Experimental studies in animals with hepatotrophic 
viruses like reo12 and rota virus have shown that these viral agents can 
reproduce some of the histological features of biliary atresia – although 
not usually the typical clinical extrahepatic appearance and sequelae. 
Seasonal variation and winter predilection for Biliary atresia have 
been described suggesting viral etiology.    
Anatomical factors : Common pancreatico-biliary channel I seen 
in <5% of normal population, whereas it is seen in 60% of infants with 
biliary atresia and 80% of infants and children with choledochal cyst13. 
When the common bile duct was ligated in experimental animals, it 
produced some of the changes of biliary atresia14. 
Acquired biliary atresia:  A rare condition, associated with 
abdominal surgeries/ healing spontaneous perforation of bile duct. Here 
intrahepatic ducts are dilated in ultrasound. They have relatively good 
prognosis. 
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CLINICAL FEATURES 
Infants with biliary atresia are usually born as AGA babies. 
Initially the newborn feeds normally and thrives normally. However as 
the obstruction progresses the child manifests with features of chronic 
liver disease and biliary cirrhosis. 
The initial symptoms will be jaundice- which can occur as a 
continuation, or after a gap of physiological jaundice, associated with 
high colored urine and persistent pale stools. Signs are usually minimal in 
the earlier stages. In the later stages child can have hepatosplenomegaly, 
ascites, and features of portal hypertension. 
The child can manifest as a case of bleeding diatheses due to vit-k 
deficient coagulopathy. Coexistent congenital anomalies like situs versus, 
malrotation can be identified. 
INVESTIGATIONS 
Early diagnosis and treatment will improve outcome. 
1. Biochemical changes : Serum conjugated hyperbilirubinemia after 
14 days of life. Serum AST, ALT, GGT elevated. Serum total 
protein and albumin normal in initial period. Serum cholesterol 
reduced. 
 15
2. Ultrasound abdomen : Rules out other surgical biliary conditions 
like choledochal cysts and inspissated bile. Used to identify biliary 
atresia by the non visualization of Gall Bladder during fasting and 
by demonstrating ‘TRIANGULAR CORD’ sign. Associated 
anomalies like situs inversus/ preduodenal portal vein/ polysplenia 
can be demonstrated. 
3. Radionuclide hepatobiliary imaging: 
Imaging with Imino Diacetic Acid (IDA) demonstrates absence of 
gut excretion of bile even after 24 hours. But there is a high 
incidence of false positive results. 
4. Percutaneous Liver Biopsy: 
5. Laparotomy with operative cholangiography: 
During cholangiography, if the entire biliary tree is visualized it 
rules out the possibility of EHBA. If the biliary tree is atretic, 
surgery is proceeded. 
TREATMENT 
There is no medical treatment. Kasai’s portoenterostomy is the 
initial step in the management of EHBA. In this surgery the atretic biliary 
tree along with gallbladder is removed and Roux-en-Y portoenterostomy 
done. Immediate postoperative complications are minimal and include 
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bleeding and persistent leak from abdominal drain. Potential 
complications that may rise in the follow-up include  
- Ascending bacterial cholangitis. 
- Portal hypertension with progressive chronic liver disease. 
- Nutritional deficiencies 
- Rare complications like intrapulmonary shunting and  very rarely 
malignant changes15. 
Children in whom the initial surgery does not produce adequate 
biliary drainage- as in 40% of cases- and those children who have 
progressive liver disease in spite of initial drainage are the candidates of 
liver transplantation16. EHBA is the most common indication of liver 
transplantation17. Redo Kasai is usually avoided in cases of potential liver 
transplantation. 
OUTCOME 
Left untreated these children usually die by 2 years or earlier. 
70 - 80% of infants operated with Kasai’s develop bile flow following 
surgery and 50%  survive to 5  years of age.18 Various studies have shown 
that 30-40% of the children survive up to 10 years with their native 
liver15, 19, 20, 21. Approximately 65% of children who undergo primary 
Kasai will ultimately require liver transplantation22, 7. 
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REVIEW OF LITERATURE 
1. Choi et al 23   in 1998 published a study from Keimyung University 
Dongsan Medical centre, Korea in which the authors reviewed the 
ultrasonographic examination and hepatobiliary scintigraphy in a 
series of 41 infants suspected of having EHBA or neonatal 
hepatitis. The triangular cord was identified in thirteen infants. In 
twelve of thirteen infants who had triangular cord sign found by 
ultrasonogram, the diagnosis of EHBA was confirmed at the time 
of Kasai procedure. The remaining one died at 15 months without 
having treatment. Twenty-seven of twenty-eight infants with absent 
triangular cord sign improved with the medical treatment for 
neonatal hepatitis on follow up. The other, diagnosed to have 
neonatal hepatitis by needle and wedge liver biopsy, eventually 
showed a triangular cord on follow up ultrasound examination 
performed 40 days after initial examination. On review of the 
hepatobiliary scintigraphy, all 13 infants with positive triangular 
cord sign had no intestinal excretion of isotope. 13 of the 28 infants 
without triangular cord also had no intestinal excretion of isotope 
in 24 hour follow up, but all of them were confirmed to have 
neonatal hepatitis by percutaneous biopsy and follow up. On the 
basis of these results the authors conclude that the triangular cord is 
 18
a very specific finding representing the fibrous cone at the porta 
hepatis and is a quick, simple, and a definitive tool in the 
noninvasive diagnosis of EHBA. If triangular cord sign is 
visualized, no further studies are required and exploratory 
laparotomy can be done. If triangular cord sign is not visualized 
hepatobiliary scintigraphy is recommended to demonstrate bile 
duct patency. Liver biopsy is required only if triangular cord sign is 
negative and there is no intestinal excretion of isotopes.                     
2. Choi et al 24   in 1999 published a study with a primary aim to 
evaluate the importance of the ultrasonographic triangular cord 
coupled with gall bladder images in the diagnostic prediction of 
EHBA from neonatal hepatitis. Seventy nine infants with 
cholestatic jaundice underwent ultrasound examination focusing in 
the triangular cord and gall bladder images. The triangular cord 
sign was defined as visualization of a triangular or band like 
periportal echogenicity (3 mm or greater in thickness), which 
represents a cone shaped fibrotic mass cranial to the portal vein in 
infants with EHBA. An abnormal gall bladder (nonvisualized or 
small) was thought to be more suggestive of EHBA than neonatal 
hepatitis. Among 25 infants with EHBA, 21 showed triangular cord 
sign, whereas 4 had no triangular cord. 53 of 54 infants with 
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neonatal hepatitis had no triangular cord, showing a diagnostic 
accuracy of 94% with a sensitivity of 84% and a specificity of 
98%. When positive triangular cord sign was coupled with an 
abnormal gall bladder the positive  predictive value was 100%, it 
decreased to 88% when a positive triangular cord was coupled with 
a normal gall bladder, it further decreased to 25% when negative 
triangular cord was coupled with an abnormal gall bladder. The 
authors concluded that the triangular cord sign appears to be a 
specific and definite ultrasonographic finding in the early diagnosis 
of EHBA. Positive triangular cord sign regardless of gall bladder 
images is highly suggestive of EHBA showing a positive predictive 
value of 95%     
3. Choi et al 25  published a study in 1996 in which the authors 
investigated whether TC was useful in the non invasive diagnosis 
of Biliary Atresia in 18 infants who had persistent neonatal 
jaundice. The triangular cord was identified in nine, and all of them 
were confirmed to have biliary atresia by histopathological 
examination. The triangular cord sign was not observed in other 
nine patients, who had neonatal hepatitis. On the basis of these 
results the authors concluded that ‘TC is a very specific 
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ultrasonographic sign, representing the fibrous cone at the porta 
hepatis, and is a useful tool in the diagnosis of EHBA’ 
4. Choi et al 26 in 1997 published a study in which the authors 
evaluated prospectively the utility of ultrasonography, Tc-99m-
DISIDA hepatobiliary scintigraphy and needle liver biopsy in 
differentiating EHBA from intrahepatic cholestasis in 73 
consecutive infants who had cholestasis. Ultrasonogram was done 
in all infants with 7.0 MHz probe focusing on the fibrous tissue in 
the porta hepatis. Although 17 of 20 ultrasonographic examinations 
from infants who had EHBA denoted triangular cord, 43 
ultrasonographic examinations from infants with either neonatal 
hepatitis or other causes of cholestasis denoted no triangular cord , 
showing a diagnostic accuracy of 95%, sensitivity of 85%, and 
specificity of 100%. Investigation with radionuclide imaging 
showed that 24 of 25 infants who had EHBA had no gut excretion, 
and 16 of 46 infants who had either neonatal hepatitis or other 
causes of neonatal cholestasis had gut excretion showing a 
diagnostic accuracy of 56%, sensitivity of 96% and specificity of 
35%. Forty four liver needle biopsies were carried out in 20 infants 
who had EHBA and 24 infants who had neonatal hepatitis or other 
cause of cholestasis. Although 18 of 20 biopsy findings in infants 
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who had EHBA were correctly interpreted as having EHBA, 23 of 
24 biopsy results in infants who had neonatal hepatitis or other 
causes of cholestasis were correctly diagnosed, showing a 
diagnostic accuracy of 93%, sensitivity of 90% and specificity of 
96%.   The study revealed that ‘The ultrasonographic TC sign is a 
simple, time saving, highly reliable, and non invasive tool in the 
diagnosis of EHBA from other causes of cholestasis. Based on 
these findings the authors proposed a new strategy in the 
evaluation of infants with neonatal cholestasis. If the TC is 
visualized prompt exploratory laparotomy is mandatory without 
further investigations. If the TC is not visualized, hepatobiliary 
scintigraphy is the next step. Excretion of tracer into the small 
bowel actually rules out EHBA. Liver biopsy is reserved only for 
the infants with no excretion of tracer. The authors conclude that 
‘the triangular cord sign seems to be a simple, time saving, highly 
reliable, and non – invasive tool in the diagnosis of biliary atresia 
from other causes of cholestasis’.                            
5. Kendric et al 27published a study in 2000 from Kandung Kerbau 
Women’s and Children’s hospital, Singapore which was done to 
evaluate the accuracy and utility of the TRIANGULAR CORD 
sign and the gallbladder length in diagnosing biliary atresia by 
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ultrasonography. Sixty five infants with cholestatic jaundice aged  
2 – 12 weeks were examined with a 5 – 10 MHz frequency probe 
focusing on triangular cord, gall bladder, and ducts. Diagnosis of 
biliary atresia was confirmed at surgery and histology. Non – 
biliary atresia infants resolved medically. Twelve infants had 
EHBA, and ten demonstrated a definite triangular cord. The two 
false negatives had small or non visualized gall bladders. No false 
positives were recorded. Scintigraphy and liver biopsy charges 
were 2 and 6 times that of sonography, respectively. The authors 
concluded that ‘the triangular cord sign and gallbladder length 
together were found to be very useful markers in the diagnosis of 
biliary atresia’. 
6. Kanegawa et al 28 from Kobe children’s hospital, Japan published a 
study in 2003. A retrospective review was performed to evaluate 
the importance of the “triangular cod” sign in comparison with 
gallbladder length and contraction for the diagnosis of biliary 
atresia in pediatric patients. Fifty – five fasting infants with 
cholestatic jaundice were examined with ultrasound focusing on 
the triangular cord sign and the size and contractility of gall 
bladder. The diagnosis of neonatal hepatitis was made if the 
symptoms resolved during follow – up. A triangular cord sign was 
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found in 27 of 29 infants with biliary atresia and in one of 26 
infants with neonatal hepatitis or other causes of neonatal 
cholestasis. The diagnostic accuracy was 95%, sensitivity was 93% 
and specificity was 96%. The gall bladder was abnormal in 21 of 
29 infants with biliary atresia, whereas it was abnormal in 8 of 26 
infants with neonatal hepatitis or other causes of neonatal 
cholestasis. The diagnostic accuracy was 71%, sensitivity was 72% 
and specificity was 69%. Gall bladder contraction was not 
confirmed in 11 of 13 infants with biliary atresia and seven of 26 
infants with neonatal hepatitis or other causes of neonatal 
cholestasis. The diagnostic accuracy was 77%, sensitivity was 85% 
and specificity was 73%. The authors concluded that ‘the triangular 
cord sign was more useful sonographic finding for diagnosing 
biliary atresia than gallbladder length and contraction’. 
7. Kotb et al 29 from department of Pediatrics and Radiology, Cairo 
university children’s hospital, Cairo, Egypt published a study in 
2001.This study prospectively studied 65 infants who presented 
with conjugated hyperbilirubinemia. All infants were subjected to 
ultrasonographic examination and the TC was assessed. The 
triangular cord was identified in 25 infants, and all of them had 
histologic features suggestive of biliary atresia. Among the 40 
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patients who did not have the triangular cord sign, 6 had paucity of 
the intrahepatic ducts, 3 had alpha – 1 - antitrypsin deficiency, and 
31 had neonatal hepatitis. Seven patients with biliary atresia were 
followed by ultrasonographic examination for 6 months after the 
Kasai portoenterostomy. The triangular cord sign disappeared in all 
cases after the surgery, however, the triangular cord sign 
reappeared in 3 patients progressive cholestasis after the procedure  
It was found that the TC sign is a simple, time saving, and reliable 
diagnostic tool in the infants with cholestasis. The triangular cord 
sign may also prove to be helpful in following patients after 
portoenterostomy.  The authors suggested a diagnostic strategy 
based on their findings. When the TC sign is visualized, the patient 
should undergo intraoperative cholangiogran to confirm the 
diagnosis of biliary atresia, reserving percutaneous liver biopsy for 
those patients in whom the TC sign could not be detected.  
8. D.K.Gupta et al 30  from  All India Institute of Medical Sciences, 
New Delhi, India published an article in 2001.The authors 
performed this retrospective study to evaluate the reliability of 
AIIMS clinical score (ACS) in differentiating neonatal hepatitis 
from extrahepatic biliary atresia. ACS is based on 5 clinical 
parameters –  age, jaundice, color of urine, pale stools, and clinical 
 25
examination of liver. 120 children referred to pediatric surgery 
department over 10 years were included in the study. Each child 
was given a score and was provisionally diagnosed either as biliary 
atresia or neonatal hepatitis clinically. The diagnosis of biliary 
atresia was established with operative cholangiography. ACS was 
favoring the diagnosis of  biliary atresia in 84 patients, with a true 
positive of 75 and a false positive of 9. ACS was favoring a 
diagnosis of neonatal hepatitis in 34 patients, with 24 true neonatal 
hepatitis cases and the remaining 7 turned out to be falsely 
concluded as neonatal hepatitis. Thus ACS showed a sensitivity of 
91.5%, specificity of 76.3%, PPV of 89.2%, NPV of 80.5%, and an 
overall diagnostic accuracy of 86.6%  
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NEED FOR THE STUDY 
EHBA and idiopathic neonatal hepatitis are two major causes of 
neonatal cholestasis syndrome. Differentiating EHBA from neonatal 
hepatitis is of paramount importance in the management of infants with 
cholestasis. The reason being early diagnosis and early surgical 
management of EHBA ( before 8th week of life ) will have relatively good 
prognosis as compared to late treatment3,18,. 
Clinical symptoms that are used to diagnose EHBA include30 
1. Persistent pale stools. 
2. Jaundice – severe and non-fluctuating. 
3. Age of clinical presentation – late onset with EHBA. 
4. Dark yellow urine. 
5. Firm liver with sharp edge. 
Of all the symptoms, persistent pale stools has been found to be 
highly diagnostic of EHBA, though it is also seen in severe forms of  
neonatal cholestasis. 
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The weightage for differentiating EHBA from idiopathic neonatal 
hepatitis is placed on investigations. The investigations that can 
differentiate EHBA from NH are; 
Ultrasonogram 
Hepatobiliary radionuclide imaging 
Peroperative cholangiogram 
Liver biopsy 
Ultrasonogram : USG can be vital in the noninvasive diagnosis of 
EHBA. Previously diagnosis was made on the basis of visualization or 
non visualization of gallbladder in a fasting infant.31.  .Recent studies 
starting in 90’s have highlighted the importance of ‘TRIANGULAR 
CORD’ sign in the diagnosis of extrahepatic biliary atresia23-30. It is a 
cord like echogenic structure identified cranial to the portal vein – 
representing the atretic extrahepatic biliary apparatus. These studies have 
concluded that TRIANGULAR CORD sign is a simple, noninvasive, 
specific, cost-effective diagnostic modality in the diagnosis of EHBA. A 
recent study has shown the usefulness  of the gall bladder ghost triad in 
the diagnosis of biliary atresia32. Hepatic artery diameter and the hepatic 
artery/portal vein diameter ratio measured by ultrasonogram has been 
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shown to be an adjunct for the ultrasonographic diagnosis of biliary 
atresia in a recent study33. 
Hepatobiliary radionuclide imaging : Hepatobiliary imaging 
using 99m-Tc Iminodiaceticacid can be used to determine the hepatic 
intake and biliary excretion. In idiopathic neonatal hepatitis, liver will 
show delay in uptake but normal excretion. In EHBA, the uptake will be 
normal, but excretion will be delayed or absent. Though radionuclide 
imaging has good sensitivity, it shows high rates of false-positivity29. Of 
late, radionuclide imaging using 99m – Tc methylbromo 
diaminoaceticacid  (mebrofenin) has been shown to be of higher 
diagnostic accuracy34. 
Studies have shown improved specificity when radionuclide study 
was done after administering Phenobarbital for 5 days. A study has 
reported the improved specificity of radionuclide scan in diagnosing 
biliary atresia if ursodeoxycholic acid was given for 2-3 days before the 
procedure35. 
Peroperative cholangiography : Peroperative cholangiography is 
an invasive procedure. In this procedure after instilling the dye in the 
gallbladder the biliary tree is imaged. Non-visualization of extrahepatic 
biliary apparatus is taken as a presumptive evidence of EHBA. 
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Percutaneous liver biopsy : Percutaneous liver biopsy shows the 
typical features of biliary atresia. But the sensitivity, specificity, 
diagnostic accuracy of this mode of investigation is highly varied.  
Diagnostic approach to EHBA in ICH, Chennai 
The diagnosis of EHBA is established in a child when he / she has 
the following features                         
- If the child presents with persistent acholic stools. 
- If 3 serial ultrasound studies with the child fasting overnight shows 
absent gall bladder. 
- If bile is not visualized with endoscope in duodenum. 
- If radionuclide imaging shows absent biliary excretion even after 
24 hours. 
- liver biopsy is generally not done in our institution because of the 
late presentation of the children, where the difference between 
neonatal hepatitis and EHBA is generally not made out in the 
biopsy specimen. 
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JUSTIFICATION OF THE STUDY 
The detection of triangular cord by ultrasonogram is a simple 
investigation modality which has been shown to be specific, cost-
effective, non invasive diagnostic modality in the diagnosis of EHBA. 
Also it is a investigation where there is no ionizing radiation exposure 
and the instrument is usually  portable and bed side diagnosis can be 
made. Evaluation of this particular sign in association with abnormal 
gallbladder is a must in our population before widespread use. Hence the 
present study intends to find the diagnostic utility of ‘triangular cord’ sign 
with abnormal gall bladder.  If found highly sensitive, specific, as other 
similar studies done elsewhere, ultrasonogram will be very useful in our 
resource constrained clinical setup, obviating the need for costly 
investigations like radionuclide imaging, liver biopsy. 
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AIM OF THE STUDY 
a. To assess the usefulness of clinical features – viz., level of 
jaundice, onset of jaundice, persistent pale stools, dark urine, 
consistency of liver taken together (AIIMS Clinical Score – ACS) 
in differentiating EHBA (Extra Hepatic Biliary Atresia) from 
neonatal hepatitis. 
b. To evaluate the usefulness of ultrasonographically determined gall 
bladder size, and ‘TRIANGULAR CORD’ sign in differentiating 
EHBA from neonatal hepatitis in isolation or in combination with 
ACS mentioned above. 
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                                 METHODOLOGY 
STUDY DESIGN 
Descriptive study 
Evaluation of a diagnostic test. 
STUDY PERIOD 
November 2006 – July 2008 
PLACE OF STUDY 
Department of Gastroenterology, Institute of Child  
Health and Hospital for Children, Chennai. 
STUDY POPULATION 
Inclusion criteria 
All infants with conjugated hyperbilirubinemia 
Exclusion criteria 
Children with other surgical causes like choledochal cyst,  
spontaneous rupture of CBD, Inspissated bile. 
SAMPLE SIZE 
A total of 30 consecutive infants with neonatal cholestasis who 
presented to the department of pediatric gastroenterology were included 
in study. 
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MANOEUVRE 
The following parameters of all the children enrolled in the study 
were noted- age of onset of jaundice, level of jaundice, color of stools, 
color of urine, consistency of liver and AIIMS clinical score was given to 
each child.  
Table 1. AIIMS clinical score: various parameters and the respective 
scores30 
Sl.No Parameters Score 
1 AGE OF PATIENT  
 <6 weeks 2 
 > 6 weeks 1 
2 JAUNDICE  
 Fluctuating, mild or moderate 2 
 Severe (bilirubin > 8 mg%) 1 
3 STOOL  
 Normal or light yellow 2 
 Mostly clay colored 1 
4 URINE  
 Normal or light yellow 2 
 Mostly dark yellow 1 
5 LIVER  
 Soft & smooth 4 
 Firm with sharp edge 1 
Interpretation 
      Score > 10 : neonatal hepatitis 
      Score < 10 : EHBA 
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All the infants who were eligible for the study were subjected to 
Ultrasonogram with a 7.0 – 10 MHz probe. The procedure was done with 
the child fasting for at least 4 hours. Size of the gallbladder was made out. 
Presence or absence of ‘TRIANGULAR CORD’ was evaluated and size 
of the cord was measured. Triangular cord sign is a cord like echogenic 
structure seen cranial to the portal vein. Studies have revealed that this 
particular sign to be present exclusively in EHBA Biliary atresia was 
diagnosed ultrasonographically if; 
1. Abnormal gall bladder-gallbladder not visualized, gallbladder 
visualized but no lumen, gallbladder  with lumen but length 
<1.5cm. 
2. TC sign >3 mm. 
If either of the findings were absent, the child was diagnosed 
ultrasonographically to have neonatal hepatitis. 
 The final diagnosis (gold standard) in biliary atresia was based on 
peroperative findings, peroperative cholangiogram and liver biopsy. 
The gold standard for the diagnosis of neonatal hepatitis was based 
on presence of intestinal excretion of radionuclide and/or reduction of 
symptoms on follow up  
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STATISTICAL ANALYSIS 
Sensitivity, specificity, positive predictive value, negative 
predictive value and overall diagnostic accuracy of  
- USG diagnosed abnormal gall bladder, 
- USG diagnosed triangular cord sign, 
- AIIMS clinical score, 
- Triangular cord sign coupled with gall bladder, 
- Triangular cord sign coupled with AIIMS clinical score, 
- Triangular cord sign coupled with gall bladder and AIIMS clinical 
score.  
against the gold standard (peroperative findings/ 
cholangiography/liver biopsy in EHBA and resolution of symptoms on 
follow up in neonatal hepatitis) among all babies presenting with features 
of neonatal cholestasis was arrived by constructing 2/2 tables.  
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RESULTS 
Table 2  
Age and sex distribution of all infants with neonatal cholestasis 
syndrome 
Age 
Total number of cases 
n (%) 
Male 
n (%) 
Female 
n (%) 
<30 days 8 (27) 8 (27) 0 (0) 
1 – 2 months 8 (27) 6 (20) 2 (7) 
2 – 3 months 6 (20) 4 (13) 2 (7) 
3 – 4 months 4 (13) 0 (0) 4 (13) 
4 – 6 months 4 (13) 4 (13) 0 (0) 
Total 30 (100) 22 (73)  8 (27) 
 
A total of 30 infants were included in the study. None of them were 
excluded. The age of these infants ranged from 20 days to 5 months with 
a median of 3 months. Out of the 30 infants, 22 (73%) were male children 
and 8 (27%) were female children with male : female ratio of 22:8. 
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Table 3 
 Sex distribution of subjects with EHBA and neonatal hepatitis 
Diagnosis Male n(%)  Female n(%)  Total n(%) 
Neonatal hepatitis 14(47) 4(13) 18(60) 
Biliary atresia  8(27) 4(13) 12(40) 
Total 22(73) 8(27) 30(100) 
 
Among the total of 30 babies with neonatal cholestasis18 (60%) 
were diagnosed to have neonatal hepatitis and 12 (40%) were diagnosed 
to have biliary atresia.  14(47%) male and 4(13%) female infants had 
neonatal hepatitis. 8 (27%) female  and 4 (13%) male infants had biliary 
atresia.     
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Table 4 
Evaluation of AIIMS clinical score in neonatal cholestasis syndrome 
AIIMS clinical 
score 
EHBA 
n(%) 
Others 
n(%) 
Total 
n(%) 
< 10 8(27) 10(33) 18(60) 
> 10 4(13) 8(27) 12(40) 
Total 12(40) 18(60) 30(100) 
 
AIIMS clinical score was 10 or more in twelve infants (40%), was 
less than 10 in eighteen infants (60%). Of the 12 infants finally diagnosed 
as EHBA, 8 (27%) infants had a score of <10, thus giving a sensitivity of 
67%. Of the 18 infants finally diagnosed to have neonatal cholestasis  due 
to cause other than EHBA, 8 (27%)had a score of >10, thus giving a 
specificity of 44%. Among the 18 children who had a AIIMS score of 
less than 10, 8 (27%)were EHBA thus giving a positive predictive value 
of 44%. Among the children who had a AIIMS score of 10 or more, 8 
(27%)were neonatal hepatitis thus giving a negative predictive value of 
67%. The overall diagnostic accuracy of this AIIMS clinical score was 
53%. 
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Table 5 
Evaluation of triangular cord sign in neonatal cholestasis syndrome 
Triangular cord 
sign 
EHBA 
n(%) 
Others 
n(%) 
Total 
n(%) 
Positive 10(33) 1(3) 11(37) 
Negative 2(7) 17(57) 19(63) 
Total 12(40) 18(60) 30(100) 
 
Triangular cord sign in ultrasound was observed in 10(33%) out of 
12 cases of EHBA giving rise to a sensitivity of 83%. The sign was not 
seen in 17(57%) of 18 cases of etiology other than EHBA giving a 
specificity of 94%. Among the total 11 children who had positive 
triangular cord sign, 10(33%) children were proved to be EHBA giving 
rise to positive predictive value of 91% and negative predictive value of 
89% as 17(57%) out of 19 children who had negative triangular cord sign 
were found to have neonatal hepatitis. In 27(90%) children out of 30 
children with neonatal cholestasis, the triangular cord sign correlated with 
the gold standard diagnosis leading to overall diagnostic accuracy of 
93%.                 
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Table - 6 
Evaluation of gall bladder in neonatal cholestasis syndrome 
Gall bladder 
EHBA 
n(%) 
Others 
n(%) 
Total 
n(%) 
Abnormal 10(33) 4(13) 14(47) 
Normal 2(7) 14(47) 16(53) 
Total 12(40) 18(60) 30(100) 
 
An abnormal gall bladder was noticed in 10(33%) cases out of 12 
cases of EHBA giving a sensitivity of 83%. A normal gall bladder was 
observed in 14(47%) of 18 cases with diagnosis other than EHBA, thus 
giving a specificity of 78%. Out of 14 cases with abnormal gall bladder, 
10(33%) had EHBA giving a positive predictive value of 71%. 14(47%) 
out of 16 cases with etiology other than EHBA had a normal gall bladder 
giving a negative predictive value of 88%. In 24(80%) children out of 30 
cases of neonatal cholestasis, the gall bladder correlated with the final 
diagnosis, thus giving a diagnostic accuracy of 80%.  
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Table 7 
Evaluation of triangular cord sign and gall bladder in neonatal 
cholestasis syndome 
 
Positive triangular cord sign 
and abnormal  gall bladder 
EHBA 
n(%) 
Others 
n(%) 
Total 
n(%) 
Yes 9(30) 0(0) 9(30) 
No 3(10) 18(60) 21(70) 
Total 12(40) 18(60) 30(100) 
                                                              
Positive triangular cord sign and abnormal gall bladder was seen in 
9 (30%) cases and all of them were EHBA. Other combinations of 
triangular cord sign and gall bladder was seen in 21 cases, out of them 
3(10%) were diagnosed as EHBA and 18(60%) were diagnosed as 
neonatal hepatitis. Thus when positive triangular cord sign and abnormal 
gall bladder were clumped together, the sensitivity, specificity, positive 
predictive value, negative predictive value, and the diagnostic accuracy in 
diagnosing EHBA was75%, 100%,  100%, 86% and 90%  respectively. 
 42
Table 8 
Evaluation of triangular cord sign and AIIMS clinical score in 
neonatal cholestasis syndrome 
Positive triangular cord 
sign and AIIMS score <10 
EHBA n(%) 
Others 
n(%) 
Total 
n(%) 
Yes 8(27) 0(0) 8(27) 
No 4(13) 18(60) 22(73) 
Total 12(40) 18(60) 30(100) 
 
Positive triangular cord sign and AIIMS score <10 was seen in a 
total of 8(27%) cases and all of them were biliary atresia. Other 
combinations of triangular cord sign and AIIMS clinical score was seen 
in 22(73%) cases, out of which 4(13%) cases were EHBA and 18(60%) 
cases were neonatal hepatitis. Thus when positive triangular cord sign 
and AIIMS clinical score <10 was clumped together, the sensitivity, 
specificity, positive predictive value, negative predictive value and 
diagnostic accuracy in diagnosing EHBA was 67%, 100%, 100%, 82% 
and 87% respectively. 
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Table 9 
Evaluation of triangular cord sign, gall bladder, AIIMS clinical score 
in neonatal cholestasis syndrome 
Positive triangular cord sign, 
abnormal gall bladder and 
AIIMS clinical score <10. 
EHBA 
n(%) 
Others 
n(%) 
Total 
n(%) 
Yes 6(20) 0(0) 6(20) 
No 6(20) 18(60) 24(80) 
Total 12(40) 18(60) 30(100) 
 
Positive triangular cord sign, abnormal gall bladder, and AIIMS 
score <10 was seen in a total of 6(20%) cases and all of them were 
EHBA. Other combinations of these findings was present in 24(80%) 
children, out of which 6(20%) were EHBA and 18(60%) were neonatal 
hepatitis.  
Thus when positive triangular cord sign, abnormal gall bladder and 
AIIMS clinical score <10 was clumped together, the sensitivity, 
specificity, positive predictive value, negative predictive value and 
diagnostic accuracy in diagnosing EHBA was 50%, 100%, 100%, 75% 
and 80% respectively. 
 [
 
 
Figure 1. Ultrasonogram showing normal porta hepatis 
  
 
 
Figure 2. Ultrasonogram showing normal gall bladder 
 
  
 
 
Figure 3.Ultrasonogram showing Triangular cord at porta hepatis 
  
 
 
Figure 4.Ultrasonogram showing Triangular cord at porta hepatis 
  
 
Figure 5. Ultrasonogram showing abnormal gall bladder  
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DISCUSSION 
Neonatal hepatitis and extra hepatic biliary atresia(EHBA) are two 
major forms of neonatal cholestasis. Children with either disease present 
with similar symptoms like jaundice, dark urine, pale stools. 
Differentiating these two conditions is important and it must be done as 
early as possible. It is important because the management of neonatal 
hepatitis and EHBA are diagonally opposite – medical management for 
neonatal hepatitis, and surgical management for EHBA.  
The need for earlier definitive diagnosis is that children with 
EHBA if operated early (< 8 weeks) will have good results as compared 
to late surgery3,18.  Clinical features, ultrasound, radionuclide imaging, 
percutaneous liver biopsy can be used to diagnose biliary atresia from 
neonatal hepatitis 
In the present study, a total of 30 subjects were included. None of 
them were excluded. Of these 30 infants, 22(73 %) were male and  
8 (27 %) were female. Biliary atresia (12 subjects ) and idiopathic 
neonatal hepatitis  (18 subjects ) made 40% and 60% of all diagnosis. The 
range of age of the subjects was 20 days to 5 months with the median of 3 
months. 
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Table 10 
Triangular cord sign - sensitivity, specificity, positive predictive 
value, negative predictive value, and diagnostic accuracy of various 
studies compared to the present one in diagnosing EHBA from 
neonatal hepatitis 
Author and 
year of 
publication 
Sensitivity 
(%)  
Specificity 
(%)  
Positive 
predictive 
value(%) 
Negative 
predictive 
value(%) 
Diagnostic 
accuracy(%)
Choi et al 
in 199823 92 96 92 96 95 
Choi et al 
in 199924 84 98 100 92 93 
Choi et al 
in 199625 100 100 100 100 100 
Choi et al 
in 199726 85 100 100 93 95 
Kendric et 
al in 200027 83 100 100 97 97 
Kanegawa 
et al in 
200328 
93 96 96 92 95 
Kotb et al 
in 200129 100 100 100 100 100 
Present 
study 83 94 91 89 93 
 
In the present study, in which 30 infants were included, the 
sensitivity, specificity, positive predictive value, negative predictive 
value, and the diagnostic accuracy of triangular cord sign was 83%, 94%, 
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91%, 89%, 93%  in diagnosing biliary atresia from neonatal hepatitis. 
Thus it can be seen that this particular sign has got a good specificity and 
positive predictive value. The results are similar to that obtained in 
similar studies done elsewhere. Almost  all these studies done to evaluate 
triangular cord sign elsewhere showed a specificity more than 96%.  
One study done by choi et al24 in 1999 had a sample size close to 
the present study. In that study, the sensitivity, specificity, positive 
predictive value, negative predictive value, and diagnostic accuracy for 
triangular cord sign in diagnosing biliary atresia was 84%, 98%, 100%, 
92%, 93% respectively.  
The sensitivity, specificity, positive predictive value, negative 
predictive value, and diagnostic accuracy of the ultrasonographically 
detected abnormal gall bladder in differentiating biliary atresia from 
neonatal hepatitis was 83%, 78%, 71%,  88%, and 80% respectively. One 
study28 has evaluated the usefulness of abnormal gall bladder and in that 
study, the sensitivity, specificity, positive predictive value, negative 
predictive value, and diagnostic accuracy of abnormal gall bladder in 
diagnosing EHBA from neonatal hepatitis was shown to be 71%, 69%, 
72%, 69%, and 71% respectively.  
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The triangular cord and abnormal gall bladder are better than 
AIIMS clinical score in differentiating biliary atresia - which showed a 
sensitivity, specificity, positive predictive value, negative predictive 
value, and diagnostic accuracy of 67%, 44%, 44%, 67% and 53% 
respectively. Only one study30 from India has assessed the usefulness of 
AIIMS clinical score and in that study it was shown to have sensitivity, 
specificity, positive predictive value, negative predictive value and the 
overall diagnostic accuracy of 91.5%, 76.3%, 89.2%, 80.5%, and 86.6% 
respectively. The difference noted can be because of the wide difference 
in the sample size between these two studies. Also, the firm liver which is 
given a score of 4 in AIIMS clinical score, was present in both biliary 
atresia and neonatal hepatitis and thus a clinical diagnosis made with 
AIIMS clinical score was not always correct when compared with gold 
standard. 
When triangular cord sign was coupled with the finding of 
abnormal gall bladder, specificity and the positive predictive value 
increased to 100% with reasonably good sensitivity, when compared to 
triangular cord sign and AIIMS clinical score combination or all the three 
parameters in combination. A study24 which showed 100% positive 
predictive value for the triangular cord sign in combination with 
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abnormal gall bladder in diagnosing EHBA from neonatal hepatitis was 
reported by choi et al. 
When triangular cord sign was coupled with AIIMS clinical score, 
again the specificity  was 100%. However the sensitivity was less when 
compared to the sensitivity of the clubbed triangular cord and abnormal 
gall bladder. When triangular cord sign was clubbed with gall bladder and 
AIIMS clinical score, the sensitivity was the lowest, with the sensitivity, 
specificity, positive predictive value, negative predictive value and 
diagnostic accuracy being 50%, 100%, 100%, 75% and 80% respectively. 
However no studies have been published, evaluating combination of 
clinical features and findings of ultrasonography in the diagnosis of 
neonatal cholestasis syndrome. 
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SUMMARY 
The present study has confirmed the high specificity and positive 
predictive value of triangular cord sign in the diagnosis of biliary atresia 
which was more than that of abnormal gall bladder and AIIMS clinical 
score considered separately. Further, when triangular cord sign was 
coupled with abnormal gall bladder and/or AIIMS clinical score the 
specificity was 100%. However clinical findings (AIIMS clinical score) 
alone had poor sensitivity and specificity in diagnosing biliary atresia. In 
view of our need for a diagnostic test which would identify EHBA 
accurately among cases of neonatal cholestasis syndrome, before going in 
for an appropriate invasive procedure, a diagnostic test with high 
specificity should be advocated; at the same time we should not miss 
cases. For this the diagnostic test should also have high sensitivity. In this 
study, ultrasonographic examination of porta hepatis and gall bladder 
looking for triangular cord and abnormal gall bladder appears to be a 
single test with high specificity and good sensitivity when compared to 
others parameters evaluated. 
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Table 11 
Sensitivity, Specificity, Positive predictive value, Negative predictive 
value & diagnostic accuracy of various parameters considered in the 
present study 
Diagnostic 
parameters 
sensitivity specificity P.P.V N.P.V 
Diagnostic 
accuracy 
AIIMS clinical score 67% 44% 44% 67% 53% 
Triangular cord sign 83% 94% 91% 89% 93% 
Gall bladder 83% 78% 71% 88% 80% 
Triangular cord and 
gall bladder 
75% 100% 100% 86% 90% 
Triangular cord and 
AIIMS clinical score 
67% 100% 100% 82% 87% 
Triangular cord, 
gall bladder, AIIMS 
clinical score 
50% 100% 100% 75% 80% 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                       CONCLUSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  51
 
CONCLUSION 
1. The combination of triangular cord sign  with abnormal gall 
bladder-both detected ultrasonographically-can be promoted as a 
diagnostic test for the diagnosis of extrahepatic biliary atresia. The 
advantage of going for the ultrasonogram as a single diagnostic 
procedure to find these two signs makes the test promising. 
2. Clinical features in the form of AIIMS clinical score alone cannot 
correctly identify biliary atresia from neonatal hepatitis.   
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ANNEXURE I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
DATA COLLECTION FORM 
Name: 
Age/sex: 
IP number: 
Admitting ward: 
Date of admission: 
Date of discharge: 
Diagnosis on discharge: 
CLINICAL FEATURES 
Jaundice    - duration 
                     Persistent / fluctuant 
Pale stools - yes / no 
Dark urine -yes / no 
Liver         - smooth / firm 
  
INVESTIGATIONS 
Level of jaundice 
Fasting ultrasonogram – triangular cord sign and gall bladder 
Radionuclide imaging (if done) 
Peroperative cholangiography 
Liver biopsy 
FOLLOW UP 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANNEXURE II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
